PRELIMINARY PROGRAM

Welcoming Reception
The residence of U.S. Ambassador to Sweden,
H.E. Michael M. Wood
Host: Stephen Noble, Deputy Chief of Mission
Welcoming remarks
Barbro C. Ehnbom,
Chairman, Swedish-American Life Science Summit

Please do not forget to bring your ID-cards!

Gold Sponsor dinner
at Kaupthing Bank

Registration

Setting the stage
Moderator, Udayan Gupta,
WSJ Journalist and Author

Introductory welcoming remarks
Filippa Reinfeldt,
Health Care Commisioner, Stockholm County Council

Keynote address
David Brennan,
CEO, AstraZeneca

Biotech innovation climate - now and in the future
Niklas Prager,
CEO, Pfizer AB

Break

Panel
The big pharma challenge
Moderator: Navroze Alphonse,
Managing Partner, Pequot Capital
Panel:
Dr. Pascale Richetta,
Head of European Business Development Team,
Abbott Laboratories
Nobel Laureate Arvid Carlsson,
Professor Emeritus, Göteborg University
Dr. Johnson Lau,
Senior Advisor, Novartis
Dr. David Naveh,
Chairman, Philogene; Advisor, Teva Pharmaceutical
Peter Utterström,
Partner, Delphi & Co
Elisabeth Legnerfält,
Senior Associate, Delphi & Co

Coffee break

Company panel presentation – “Proteomics”
Commentary: Professor Mathias Uhlén,
Royal Institute of Technology
Presenting companies:
Atlas Antibodies, Dr. Marianne Hansson, CEO 
Affibody, Dr. Lars Abrahmsén, CSO

Lunch
Welcome: Torsten Lyth,
CEO, Ernst & Young AB

The state of big pharma :
How we got here and where is here?
Frederick Frank,
Vice Chairman, Lehman Brothers

Break

Panel
Alternative financing, what works in this environment?
Moderator: Udayan Gupta,
WSJ Journalist & Author
Panel:
Les Clifford,
Life Science Practice, Ernst & Young
J. Jay Lobell,
President, Paramount BioCapital
Dr. Eugen Steiner,
Partner, HealthCap
Dr. Francesco De Rubertis,
General Partner, Index Ventures
William Gedale,
Managing General Partner, NGN Capital

Concluding remarks by moderator

Dinner Cruise sponsored by Kaupthing Bank
Host & Speaker: Robert Charpentier,
CEO, Kaupthing Bank Sverige AB

Coffee reception

Synthetic biology - a new frontier for medicine and the environment
Dr. William Haseltine,
Chairman, Haseltine Global Health

Panel
Success stories, what works in the US and Sweden respectively?
Moderator: Dr. Yuval Binur,
Managing General Partner, Accelerated Technologies
Panel:
Mohammed Homman,
CEO, Vironova
Hans Dahlin,
CEO, ONCOlog Medical
Lars Hellerung Christiansen,
Director Business Development, Prosidion
Ingemar Lagerlöf,
CEO, LinkMed AB

Coffee break

Company panel presentation - "CNS-diseases"
Presenting companies:
Intra-Cellular Therapies, Dr. Sharon Mates, CEO
Biovitrum, Dr. Martin Nicklasson, CEO
Neuronova, Dr. Anders Haegerstrand, CSO

Private equity in the medtech field. 
The Dako and Hemocue examples.
Thomas von Koch,
Senior Partner, EQT

Final Remarks - Moderator

Luncheon at Operakällaren (the Terrace)
Address: Operahuset, Karl XII:s torg, Stockholm
Keynote speaker: Jacob Wallenberg,
Chairman, Investor AB

Concluding remarks: Professor Jesper Tegnér,
CSO, Clinical Gene Networks